Chinese Insulin Product Approved as First Insulin Glargine Biosimilar in Pakistan
The insulin glargine cartridge by Gan & Lee Pharmaceuticals just obtained the first biosimilar approval from the Drug Regulatory Authority of Pakistan (DRAP), a move expected to increase the accessibility of glucose-lowering medications in the local market. Data shows that Pakistan has 34.5 million diabetic patients aged 20-79…
The insulin glargine cartridge by Gan & Lee Pharmaceuticals just obtained the first biosimilar approval from the Drug Regulatory Authority of Pakistan (DRAP), a move expected to increase the accessibility of glucose-lowering medications in the local market. Data shows that Pakistan has 34.5 million diabetic patients aged 20-79…
Read More
About Author
